- The FDA just approved elagolix, a new treatment for women living with endometriosis.
- Endometriosis, a condition that affects millions of women, occurs when tissue from the uterus grows outside of it, leading to cysts, heavy bleeding, and scarring.
- It’s the first new treatment in a pill form for the disorder in more than a decade.
The FDA just approved a new treatment for endometriosis.
The drug, elagolix — now marketed as Orilissa — is made by AbbVie in partnership with Neurocrine Biosciences, and it’s taken as a daily pill.
It’s the first new treatment for the disorder in a pill form in more than a decade. See the rest of the story at Business Insider
- Pharma giant Merck just lowered the prices of some of its medications
- The FDA just approved a new cancer drug that’s part of a groundbreaking approach to tackling the disease
- ‘It’s akin to us cancelling scheduled ice fishing trips during July and August:’ Trump is claiming a win after drugmakers committed not to increase prices for the rest of the year but it could have little impact on patients